The US FDA had inspected Aurobindo's Unit-7 between January 28 and February 10, 2026. The inspection observations pointed to ...
The shares of Aurobindo Pharma will be in focus in today's session, as the USFDA issued a Form 483 with a total of nine observations post the inspection. The Hyderabad-based company, in an exchange ...